A second trial was conducted in America to hopefully duplicate the modest but great results of Rilutek. Myotrophin is made by an American company called Cephalon. A second trial of Myotrophin was conducted in Europe where it didn't perform as well as in the United States. Of course not. They want Cephalon to conduct a third trial.
People dying of a terminal disease only want access to the best medicine possible.
Many of us know Myotrophin is safe, because we have used it for years. Many people with ALS have contacted NORD and asked how they might express their disappointment with the FDA's Advisory Committee's recommendation and request that the agency rejects the committee's recommendation. Personal letters should be written to the two Senators and district Congressperson in which the writer resides. Rather, they advised FDA not to approve it. The final decision rests in the hands of FDA Administrators, and they can decide NOT to take the advisory committee's advice.